Analyst Price Targets — BAX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 31, 2026 11:15 am | — | Stifel Nicolaus | $28.00 | $26.75 | TheFly | Baxter price target raised to $28 from $24 at Stifel |
| July 28, 2026 12:10 pm | — | UBS | $25.00 | $24.49 | TheFly | Baxter price target raised to $25 from $19 at UBS |
| July 28, 2026 10:50 am | Rick Wise | Stifel Nicolaus | $24.00 | $23.34 | TheFly | Baxter price target raised to $24 from $19 at Stifel |
| July 15, 2026 10:20 am | — | Goldman Sachs | $21.00 | $21.80 | TheFly | Baxter price target raised to $21 from $19 at Goldman Sachs |
| July 6, 2026 12:40 pm | Vijay Kumar | Evercore ISI | $24.00 | $22.22 | TheFly | Baxter price target raised to $24 from $22 at Evercore ISI |
| May 4, 2026 9:13 am | — | Barclays | $27.00 | $17.21 | TheFly | Baxter price target raised to $27 from $25 at Barclays |
| February 17, 2026 3:01 pm | — | Goldman Sachs | $17.00 | $20.54 | TheFly | Baxter price target lowered to $17 from $21 at Goldman Sachs |
| February 16, 2026 12:51 pm | Danielle Antalffy | UBS | $19.00 | $19.79 | TheFly | Baxter price target lowered to $19 from $21 at UBS |
| February 13, 2026 1:36 pm | — | Deutsche Bank | $20.00 | $19.23 | TheFly | Baxter price target lowered to $20 from $22 at Deutsche Bank |
| February 13, 2026 11:08 am | — | Barclays | $25.00 | $18.71 | TheFly | Baxter price target lowered to $25 from $30 at Barclays |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for BAX

Barbara Oil Co. purchased a new position in Baxter International Inc. (NYSE: BAX) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 40,000 shares of the medical instruments supplier's stock, valued at approximately $853,000. Several other hedge funds also recently made changes

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed John Rogers as executive vice president and chief financial officer (CFO), reporting to Baxter president and chief executive officer (CEO), Andrew Hider, effective Oct. 1, 2026. “John is a proven global finance executive with extensive operational expertise and a successful track record…

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced the pricing terms for its previously announced cash tender offers (each, an “Offer” and collectively, the “Offers”) of the Company's validly tendered (and not validly withdrawn) notes set forth below (the “Notes”) using a “waterfall” methodology under which the Company will accept the Notes in order of…

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced the early results of its previously announced cash tender offers (each, an “Offer” and collectively, the “Offers”) for its validly tendered (and not validly withdrawn) notes set forth below (collectively, the “Notes”). The Offers are being made pursuant to an Offer to Purchase, dated Aug. 4, 2026 (as it…

On August 17, 2026, Baxter International Inc (BAX) shares fell 3.1% to a current price of $25.91. This decline comes amid a 52-week price range of $15.73 to $30
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
